CD82 Recombinant Antbody Kit (KD-Validated)
Applications
Reactivity
| Overview | |
| Catalog # | bsm-90245r-50uL |
| Product Name | CD82 Recombinant Antbody Kit (KD-Validated) |
| Applications |
WB
FCM
IC
|
| Specificity | Knockdown Validated |
| Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | A synthesized peptide derived from human CD82 |
| Immunogen Range | 200-267/267 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Affinity Purified |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | -20°C |
| Target | |
| Gene ID | 3732 |
| Swiss Prot | P27701 |
| Synonyms | CD82; CD82 Molecule 2; TSPAN27; IA4; CD82 Antigen; KAI1; R2; Kangai 1 (Suppression Of Tumorigenicity 6 Prostate; CD82 Antigen (R2 Leukocyte Antigen Antigen Detected By Monoclonal And Antibody IA4)); Metastasis Suppressor Kangai-1; Inducible Membrane Protein R2; Tetraspanin-27; C33 Antigen; Tspan-27; SAR2; Suppressor Of Tumorigenicity 6 Protein; Suppression Of Tumorigenicity 6; R2 Leukocyte Antigen; GR15; 4F9; C33 |
| Background | Cell Line: HT-1080 Knockdown technology: shRNA Knockdown |
| Application Dilution | |
| WB | 1:300-5000 |
| FCM | 1:20-100 |
| IC | 1:1000 |